Dr. Oliver Schoppe appointed Partner at UVC Partners

Munich, Germany – February 17, 2026 – Dr. Oliver Schoppe has been appointed to the leadership team of UVC Partners. He invests primarily in Software, Artificial Intelligence, and TechBio/Health. With his appointment, UVC Partners further strengthens its commitment to technological excellence and an entrepreneurial perspective within the partnership.

Oliver Schoppe has been part of the UVC Partners investment team since 2021 and was quickly promoted to Principal. Since joining, he has played a key role in investments such as Aleph Alpha, Patronus, Reel, Paretos, Rencore, Biomatter, Sonia, as well as additional undisclosed investments. With this step, UVC Partners expands its partnership and reinforces the fund's long-term development. All existing partners will continue in their roles on a long-term basis. Oliver’s portfolio responsibilities and thematic focus also remain unchanged.

By joining the partnership, Oliver underscores his long-term commitment to UVC Partners. Since joining the firm, he has focused on jointly advancing the fund and shaping its investment strategy. He particularly values UVC Partners’ strong technological focus, its alliance with the UnternehmerTUM ecosystem, and the trust-based, long-term collaboration among the partners.

“Oliver combines exceptional depth at the intersection of artificial intelligence and the natural sciences with strong transaction experience in strategic M&A and private equity. This combination enables him not only to assess technological developments from a scientific perspective but also to translate them into attractive investment opportunities. In addition, he brings a strong commitment to the continuous development of UVC Partners – whether through further building our platform, mentoring junior team members, or shaping our partnerships,” said Johannes von Borries, Managing Partner at UVC Partners.

Looking ahead, Oliver outlines the priorities he sees within the partnership.

“The current moment marks a period of transition in venture capital. Artificial intelligence, in particular, is reshaping the rules of the game – not only in software, but across almost all industries. We are at the beginning of a technological transformation with unprecedented potential. In this context, UVC Partners is very well positioned to back some of the most exciting companies across Europe, from pre-seed to exit across all stages,” Oliver said.

Background on Dr. Oliver Schoppe

So far, Oliver served as a Principal at UVC Partners, focusing on early-stage investments in artificial intelligence, enterprise SaaS, data-driven business models, digital health, and TechBio.

Prior to his career in venture capital, Oliver gained extensive experience at McKinsey & Company, where he advised industrial companies and private equity funds on growth strategy, IPOs, and M&A transactions.

His academic background spans electrical engineering, neuroscience, computer science, and artificial intelligence. He studied at leading institutions, including the Technical University of Munich, the University of Oxford, Harvard, and MIT.

“We are very pleased to welcome Oliver to our partnership. With his profile and mindset, he is a strong addition to our firm,” said Dr. Ingo Potthof, Managing Partner at UVC Partners.

About UVC Partners

UVC Partners is a leading venture capital firm investing in European B2B tech startups, with offices in Munich and Berlin. Managing over €600 million in assets, UVC Partners typically invests between €1million and €10 million initially, with up to €30 million per startup, focusing on DeepTech, ClimateTech, Mobility, and Software/AI. As an independent partner of UnternehmerTUM – Europe’s leading startup ecosystem – UVC Partners has unique access to proprietary deal flow, over 1,000 corporates and SMEs, and top talent from the Technical University of Munich, one of Europe’s leading technical universities. UVC Partners' portfolio includes Flix, Isar Aerospace, planqc, Proxima Fusion, Reverion, Tacto, TWAICE, DeepDrive, STABL, and many more. All portfolio companies and founders benefit from the team’s extensive investment and exit experience, its ability to build sustainable industry leaders, and theUnternehmerTUM network – particularly when it comes to accelerating market entry.

Website: www.uvcpartners.com